Pharmacy

Flovent HFA Discontinuation on the MS Medicaid Universal Preferred Drug List (PDL) Flovent HFA (fluticasone propionate inhalation aerosol) was...

In its first year of implementation, a new pharmacy program at the Mississippi Division of Medicaid (DOM) aimed at...

The Mississippi Coordinated Access Network (MSCAN) Coordinated Care Organizations (CCOs) must reimburse network providers in accordance with Division of...

The Mississippi Division of Medicaid (DOM) requires enrolled providers to be in good standing with all applicable regulatory authorities....

The Mississippi Division of Medicaid’s (DOM) Universal Preferred Drug List (PDL) underwent an annual review on Nov. 2, 2017....

The Mississippi Division of Medicaid (DOM) has heard pharmacy providers’ concerns and adjusted the claims reprocessing schedule originally noted...

A new pharmacy reimbursement methodology for the Mississippi Division of Medicaid (DOM) impacts both fee-for-service and MississippiCAN pharmacy claims....

The Mississippi Division of Medicaid (DOM) submitted State Plan Amendment (SPA) 17-0002 Pharmacy Reimbursement to the Centers for Medicare...

The Mississippi Division of Medicaid (DOM) is further delaying 340B billing policy implementation pending Centers for Medicare and Medicaid...

Pharmacy Reimbursement changes will be implemented retrospectively upon CMS State Plan Amendment (SPA) approval On February 1, 2016, the...